Ticker

Shares of LogicBio Therapeutics, Inc. (OTCMKTS:LOGC - Get Free Report) fell 0.6% during mid-day trading on Thursday. The stock traded as low as $7.98 and last traded at $8.26. 7,831 shares were traded during mid-day trading, a decline of 90% from the average session volume of 74,876 shares. The stock had previously closed at

OAKLAND, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”), a business ownership platform focused on acquiring and building a portfolio of high-quality, long-duration businesses, today announced that its Board of Directors (“the Board”) has appointed Paul S.

OAKLAND, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2025.

Stock News Paramount tops Netflix for WBD: Warner Bros. Discovery (WBD) chose Paramount Skydance's (PSKY) $31-per-share bid over Netflix's (NFLX) $27.75 offer,

Stock News Paramount edges Netflix for WBD: Paramount Skydance (PSKY) emerged as the preferred bidder for Warner Bros. Discovery (WBD), after Netflix (NFLX) wit